Filing Details
- Accession Number:
- 0001209191-21-048429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-28 16:32:26
- Reporting Period:
- 2021-07-26
- Accepted Time:
- 2021-07-28 16:32:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | Biological Products, (No Disgnostic Substances) (2836) | 464233385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1813800 | Jeff Fairman | C/O Vaxcyte, Inc. 353 Hatch Drive Foster City CA 94404 | Vp, Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-26 | 4,750 | $1.79 | 9,894 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-26 | 4,750 | $22.70 | 5,144 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-07-26 | 4,750 | $0.00 | 4,750 | $1.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,095 | 2027-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 341,227 | Indirect | By Fairman Family Trust |
| Common Stock | 50,000 | Indirect | By AF 2020 Irrevocable Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $22.50 to $22.935. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
